<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03915275</url>
  </required_header>
  <id_info>
    <org_study_id>7407</org_study_id>
    <nct_id>NCT03915275</nct_id>
  </id_info>
  <brief_title>Clinical Impact of 16S rDNA PCR</brief_title>
  <acronym>CI16DP</acronym>
  <official_title>Clinical Impact of 16S rDNA PCR, a Monocentric Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to evaluate the impact of a positive 16S rDNA PCR in
      various sites on patient's management.

      The secondary objectives of the protocol are:

        -  to evaluate bacterial identification performance

        -  to evaluate the effect of previous antibiotic therapy

        -  to analyze the management of discordant results between 16S PCR and culture
           identification
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2019</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Study of the modification of the care of the patients by the use of the 16S PCR</measure>
    <time_frame>The period from Junuary 1st, 2014 to Dcember 31, 2018 will be examined</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Bacterial Infections</condition>
  <eligibility>
    <study_pop>
      <textblock>
        tients that had a 16S rDNA PCR positive result in Strasbourg University Hospital laboratory
        from 2014 to 2018
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients that had a 16S rDNA PCR positive result in Strasbourg University Hospital
             laboratory from 2014 to 2018

          -  Patients consent for this analysis of their past medical history

          -  Legal guardians consent for the analysis of their children's medical history

        Exclusion Criteria:

          -  Patients who express opposition for this study

          -  Incomplete clinical record
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Xavier ARGEMI, MD</last_name>
    <phone>33 3 69 55 11 87</phone>
    <email>xavier.argemi@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service de Maladies Infectieuses et Tropicales</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Xavier ARGEMI, MD</last_name>
      <phone>33 3 69 55 11 87</phone>
      <email>xavier.argemi@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 11, 2019</study_first_submitted>
  <study_first_submitted_qc>April 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2019</study_first_posted>
  <last_update_submitted>April 11, 2019</last_update_submitted>
  <last_update_submitted_qc>April 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacterial Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

